First line anti-tuberculous drug resistance prevalence and its pattern among HIV infected patients in the national referral TB center, Iran

P. Tabarsi, E. Chitsaz, A. Moradi, P. Baghai, M. Marjani, M. Masjedi (Tehran, Islamic Republic Of Iran)

Source: Annual Congress 2009 - Tuberculosis and HIV co-infection
Session: Tuberculosis and HIV co-infection
Session type: E-Communication Session
Number: 3314
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. Tabarsi, E. Chitsaz, A. Moradi, P. Baghai, M. Marjani, M. Masjedi (Tehran, Islamic Republic Of Iran). First line anti-tuberculous drug resistance prevalence and its pattern among HIV infected patients in the national referral TB center, Iran. Eur Respir J 2009; 34: Suppl. 53, 3314

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
First-line anti-TB drug resistance pattern and its trend in the national TB referral center in Iran
Source: Annual Congress 2008 - Clinical epidemiology of tuberculosis III
Year: 2008

Investigating trends in antituberculosis (anti-TB) drug resistance among treated patients of a university respiratory infections unit in Greece
Source: Annual Congress 2009 - Treatment of tuberculosis at times of emerging drug resistance
Year: 2009


Pattern of second line drug-resistance in MDR-TB treatment failure cases at a tertiary care tuberculosis treatment centre in western region of India
Source: International Congress 2016 – Update on drug-resistant tuberculosis
Year: 2016


Impact of extensive drug resistance on treatment outcomes in non-HIV infected adults with MDR-TB
Source: Annual Congress 2007 - Multidrug-resistant tuberculosis and the emerging threat of extensively drug-resistant tuberculosis
Year: 2007


Antituberculous drug resistance rates in soldier patients newly diagnosed with TB in Turkey
Source: Annual Congress 2010 - Tuberculosis drug resistance
Year: 2010

Frequency of drug resistance and treatment results with standard chemotherapeutical regimen in patients with newly detected tuberculosis on the data of district hospital, Kiev
Source: Eur Respir J 2002; 20: Suppl. 38, 548s
Year: 2002

Frequency of drug resistance and treatment results in patients with newly detected tuberculosis using standard chemotherapeutical regimen on the data of district hospital, Kiev
Source: Eur Respir J 2002; 20: Suppl. 38, 402s
Year: 2002

Incidence of TB latent infection in health care workers in a low TB prevalence country
Source: Annual Congress 2005 - Epidemiology and control of tuberculosis and LTBI
Year: 2005


Tuberculosis in HIV-infected persons in the context of wide availability of highly active antiretroviral therapy
Source: Eur Respir J 2004; 24: 11-17
Year: 2004



Treatment outcome of multi-drug resistant tuberculosis (MDR-TB) patients at a tertiary care center of Northern India.
Source: International Congress 2019 – Tuberculosis and non-TB mycobacterial infection II
Year: 2019

The association between HIV and antituberculosis drug resistance
Source: Eur Respir J 2008; 32: 718-725
Year: 2008



TB and drug-resistant TB report from a referral TB unit of Athens. The impact of immigration during the years 1995–2000
Source: Annual Congress 2003 - The various appearance of resistance
Year: 2003


Study of prevalence of drug resistance in tuberculosis (TB) patients attending a tertiary care hospital at Mumbai
Source: International Congress 2016 – Epidemiological insights into tuberculosis pathogenesis
Year: 2016


Is prevalence of MDR TB and XDR TB decreasing in a tertiary care hospital in India?
Source: International Congress 2017 – MDRTB: detection and management
Year: 2017


Low prevalence of fluoroquinolone resistance among patients with tuberculosis in the Philippines: results of a national survey
Source: Eur Respir J, 51 (3) 1702571; 10.1183/13993003.02571-2017
Year: 2018



HIV co-infection excludes many drug-resistant tuberculosis patients from clinical trials with novel antituberculosis drugs
Source: International Congress 2015 – TB treatment: new drugs and drug resistance
Year: 2015

Prevalence and treatment outcome of drug resistant pulmonary tuberculosis in HIV negative cases – experience from a tuberculosis treatment center in India
Source: Annual Congress 2009 - Multi/extensively-drug resistant tuberculosis
Year: 2009


The influence of a TB ward in a high TB incidence Romanian area
Source: Eur Respir J 2005; 26: Suppl. 49, 198s
Year: 2005

Resistance pattern to WHO category IV anti tuberculous drugs in patients suspected of multidrug resistance tuberculosis presenting to a specialist clinic in Maharashtra, India
Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: epidemiology II
Year: 2012

Frequency of risk factors for multi-drug resistant tuberculosis among the patients enrolled at multi-drug resistant clinic in a tertiary care hospital, Pakistan
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 1
Year: 2014